Medicare Drug Cuts Target CVD Meds, Drive Debates
CardiacWire
AUGUST 18, 2024
The White House finally unveiled its negotiated Medicare drug prices , bringing 38%-76% reductions to the first 10 drugs, while drawing mixed industry reactions. Medicare drug price negotiations are one of the highlighted results of 2022’s Inflation Reduction Act, allowing CMS to negotiate drug prices for the very first time.
59 
Let's personalize your content